Copenhagen Master Observational Trial
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The primary objectives of this prospective non-interventional study (NIS) are to assess and describe outcomes in relation to biomarkers, including whole-genome sequencing (WGS) in patients with non- small cell lung cancer (NSCLC) or breast cancer receiving treatment offered in the clinic (standard of care or included in clinical trials).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Rozpoznanie raka płuc (NSCLC) lub raka piersi, który można leczyć
- •Świadoma zgoda pacjenta na udział w badaniu
- •Umiejętność czytania i rozumienia języka duńskiego
- •Chęć i możliwość uczestniczenia w zbieraniu danych genetycznych
✗ Disqualifies
- •Rak piersi w stadium początkowym wymagający chemioterapii pomocniczej (terapii poprawiającej szanse po operacji)
- •Oczekiwana długość życia poniżej 3 miesięcy w momencie diagnozy
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 12, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Rigshospitalet
Copenhagen, Denmark
Trial contact
Ulrik Lassen, MD
Andreas Bjerrum, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/13/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.